Glenmark launches COVID-19 drug after DCGI nod

The company hopes that the availability of an effective treatment such
as FabiFlu will considerably help assuage this pressure, and offer
patients in India a much needed and timely therapy option, he added.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-launches-covid-19-drug-after-dcgi-nod/articleshow/76479268.cms

Comments

Popular posts from this blog

The Scroll and the Revolution: The Dilemmas of Writing about the Jews of Cuba

MAHE Manipal Research Fellow Jobs – Biotech / Mol Bio / Microbiology Apply

The Right Tool for the Job: Foreign Policy Effectiveness and Nuclear Proliferation